Kristien Van der Elst

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2014 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2016 · 114 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Sleep Problems in Patients with Rheumatoid Arthritis

René Westhovens, Kristien Van der Elst, Ann Matthys et al. · The Journal of Rheumatology · 2013 · 109 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON’T RETARD project

Deborah Hilderson, Philip Moons, Kristien Van der Elst et al. · Lara D. Veeken · 2015 · 70 citations · Full text

Medicine, Pediatrics, Adolescent Health +16

Unraveling Patient‐Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study

Kristien Van der Elst, Sabrina Meyfroidt, Diederik De Cock et al. · Arthritis Care & Research · 2015 · 68 citations · Full text

Pharmacy, Clinical Sciences, Outcomes Research +16